{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:46:50Z","timestamp":1791859610340,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22476167"],"award-info":[{"award-number":["22476167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22522609"],"award-info":[{"award-number":["22522609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001483-00"],"award-info":[{"award-number":["MOH-001483-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001334-00"],"award-info":[{"award-number":["MOH-001334-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001254-00"],"award-info":[{"award-number":["MOH-001254-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2021\/034\/TRP\/09\/Nanomedicine"],"award-info":[{"award-number":["NUHSRO\/2021\/034\/TRP\/09\/Nanomedicine"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2021\/097\/Startup\/13"],"award-info":[{"award-number":["NUHSRO\/2021\/097\/Startup\/13"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2023\/008\/NUSMed\/TCE\/LOA"],"award-info":[{"award-number":["NUHSRO\/2023\/008\/NUSMed\/TCE\/LOA"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["ODPRT 23\\u20130173-A0001"],"award-info":[{"award-number":["ODPRT 23\\u20130173-A0001"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["rcyj-202603"],"award-info":[{"award-number":["rcyj-202603"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.addr.2026.115978","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:18:03Z","timestamp":1791587883000},"page":"115978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bioorthogonal chemistries for theranostics and radioconjugates"],"prefix":"10.1016","volume":"239","author":[{"given":"Kaiqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fantian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2026.115978_bb0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2967\/jnumed.123.265670","article-title":"What is Theranostics?","volume":"64","author":"Weber","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.addr.2026.115978_bb0015","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1021\/jacs.4c15896","article-title":"Pretargeted multimodal tumor imaging by enzymatic self-immobilization labeling and bioorthogonal reaction","volume":"147","author":"Miao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-022-01250-1","article-title":"Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry","volume":"7","author":"Yi","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.addr.2026.115978_bb0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115978_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41420-023-01778-3","article-title":"Carrier systems of radiopharmaceuticals and the application in cancer therapy","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.addr.2026.115978_bb0040","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/acs.accounts.3c00309","article-title":"Exploiting albumin as a versatile carrier for Cancer Theranostics","volume":"56","author":"Tao","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2026.115978_bb0045","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.apsb.2022.03.009","article-title":"Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development","volume":"12","author":"Lai","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2026.115978_bb0050","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2967\/jnumed.125.269933","article-title":"Development of an optimized CXCR4-targeting Theranostic pair","volume":"67","author":"Kwon","year":"2026","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0055","first-page":"21","article-title":"Synthesis and evaluation of novel 68Ga-labeled GRPR-targeted PET tracers derived from [d-Phe6,Pro14]Bombesin(6\u201314) and [d-Phe6,des-Met14]Bombesin(6\u201314) sequences","volume":"12","author":"Jozi","year":"2026","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0060","doi-asserted-by":"crossref","first-page":"21644","DOI":"10.1021\/acs.jmedchem.4c01608","article-title":"Current status and perspectives of novel radiopharmaceuticals with heterologous dual-targeted functions: 2013\u20132023","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115978_bb0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acscentsci.3c00288","article-title":"Covalent proteins as targeted radionuclide therapies enhance antitumor effects","volume":"9","author":"Klauser","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.addr.2026.115978_bb0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115978_bb0080","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.chempr.2023.05.016","article-title":"Bioorthogonal chemistry: bridging chemistry, biology, and medicine","volume":"9","author":"Hartung","year":"2023","journal-title":"Chem"},{"key":"10.1016\/j.addr.2026.115978_bb0085","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.chempr.2023.04.004","article-title":"Bioorthogonal reactions and AIEgen-based metabolically engineered theranostic systems","volume":"9","author":"Kenry","year":"2023","journal-title":"Chem"},{"key":"10.1016\/j.addr.2026.115978_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s41061-025-00495-y","article-title":"Toward realization of bioorthogonal chemistry in the clinic","volume":"383","author":"de Roode","year":"2025","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5603\/nmr.105942","article-title":"Prospects of click chemistry reactions in nuclear medicine: the TCO-Tz reaction based on the IEDDA mechanism","volume":"28","author":"Jing","year":"2025","journal-title":"Nucl. Med. Rev. Cent. East. Eur."},{"key":"10.1016\/j.addr.2026.115978_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nchembio0605-13","article-title":"Chemistry in living systems","volume":"1","author":"Prescher","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115978_bb0105","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1021\/ja044996f","article-title":"A strain-promoted [3 + 2] Azide\u2212alkyne cycloaddition for covalent modification of biomolecules in living systems","volume":"126","author":"Agard","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0110","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115978_bb0115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.31635\/ccschem.023.202202593","article-title":"Proximity chemistry in living systems","volume":"5","author":"Liu","year":"2023","journal-title":"CCS Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0120","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/jacs.8b11747","article-title":"Chemistry for covalent modification of endogenous\/native proteins: from test tubes to complex biological systems","volume":"141","author":"Tamura","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-021-00028-z","article-title":"Bioorthogonal chemistry","volume":"1","author":"Scinto","year":"2021","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.addr.2026.115978_bb0130","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1021\/jacs.4c15986","article-title":"Not so bioorthogonal chemistry","volume":"147","author":"Schauenburg","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0135","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1126\/science.287.5460.2007","article-title":"Cell surface engineering by a modified Staudinger reaction","volume":"287","author":"Saxon","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115978_bb0140","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/ol006054v","article-title":"A \u201ctraceless\u201d Staudinger ligation for the Chemoselective synthesis of amide bonds","volume":"2","author":"Saxon","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/j.addr.2026.115978_bb0145","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acs.chemrev.9b00665","article-title":"The Staudinger ligation","volume":"120","author":"Bednarek","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2026.115978_bb0150","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1002\/anie.201800860","article-title":"Site-selective cysteine-Cyclooctyne conjugation","volume":"57","author":"Zhang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115978_bb0155","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.ccr.2011.06.028","article-title":"The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) \u201cclick\u201d reaction and its applications. An overview","volume":"255","author":"Liang","year":"2011","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.addr.2026.115978_bb0160","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1039\/C6CC01321J","article-title":"A simple method for enhancing the bioorthogonality of cyclooctyne reagent","volume":"52","author":"Tian","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2026.115978_bb0165","doi-asserted-by":"crossref","first-page":"13518","DOI":"10.1021\/ja8053805","article-title":"Tetrazine ligation: fast bioconjugation based on inverse-Electron-demand Diels\u2212Alder reactivity","volume":"130","author":"Blackman","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0170","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/bc400153y","article-title":"Highly reactive trans-cyclooctene tags with improved stability for Diels-Alder chemistry in living systems","volume":"24","author":"Rossin","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0175","series-title":"Cycloadditions in Bioorthogonal Chemistry","first-page":"109","article-title":"Inverse Electron-Demand Diels\u2013Alder Bioorthogonal Reactions","author":"Wu","year":"2016"},{"key":"10.1016\/j.addr.2026.115978_bb0180","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1039\/D2CS00889K","article-title":"Bioorthogonal chemistry for prodrug activation in vivo","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2026.115978_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nchembio.2024","article-title":"Development and application of bond cleavage reactions in bioorthogonal chemistry","volume":"12","author":"Li","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2026.115978_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nchem.480","article-title":"A biocompatible condensation reaction for controlled assembly of nanostructures in living cells","volume":"2","author":"Liang","year":"2010","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0195","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1002\/anie.200903627","article-title":"A biocompatible condensation reaction for the labeling of terminal cysteine residues on proteins","volume":"48","author":"Ren","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115978_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116881","article-title":"Recent applications of CBT-Cys click reaction in biological systems","volume":"68","author":"Zhu","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/cbmi.3c00117","article-title":"Enzyme-instructed CBT-Cys-like click cyclization reactions for bioimaging","volume":"2","author":"Yang","year":"2024","journal-title":"Chem. Biomed. Imaging"},{"key":"10.1016\/j.addr.2026.115978_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","article-title":"A bioorthogonal system reveals antitumour immune function of pyroptosis","volume":"579","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115978_bb0215","doi-asserted-by":"crossref","first-page":"19750","DOI":"10.1002\/anie.202106526","article-title":"A cationic micelle as in vivo catalyst for tumor-localized cleavage chemistry","volume":"60","author":"Wang","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115978_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126236","article-title":"Emerging paradigms in bioorthogonal chemistry for future therapeutics","volume":"685","author":"\u00d6nder","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0225","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1039\/D1CS00451D","article-title":"Metal-free bioorthogonal click chemistry in cancer theranostics","volume":"51","author":"Wu","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2026.115978_bb0230","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2967\/jnumed.112.115550","article-title":"The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals","volume":"54","author":"Zeng","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0235","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S1470-2045(19)30821-6","article-title":"Radiotheranostics: a roadmap for future development","volume":"21","author":"Herrmann","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.addr.2026.115978_bb0240","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2967\/jnumed.117.189944","article-title":"Pretargeted imaging and therapy","volume":"58","author":"Altai","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0245","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2967\/jnumed.121.262186","article-title":"Pretargeting: a path forward for radioimmunotherapy","volume":"63","author":"Cheal","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0250","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1078-0432.CCR-20-2150","article-title":"A self-assembling and disassembling (SADA) bispecific antibody (BsAb) platform for curative two-step pretargeted radioimmunotherapy","volume":"27","author":"Santich","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115978_bb0255","unstructured":"M.Z. Zhengsheng Yao, Kayhan Garmestani, Donald B Axworthy, Robert W Mallett, Alan R Fritzberg, Lou J Theodore, Paul S Plascjak, William C Eckelman, Thomas A Waldmann, Ira Pastan, Chang H Paik, Martin W Brechbiel, Jorge A Carrasquillo, Pretargeted alpha emitting radioimmunotherapy using 213Bi 1,4,7,10-tetraazacyclododecane-N,N',N\",N\"'-tetraacetic acid-biotin, Clin. Cancer Res., 10 (2004) 9."},{"key":"10.1016\/j.addr.2026.115978_bb0260","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2967\/jnumed.118.208348","article-title":"Radionuclide therapy of HER2-expressing human xenografts using Affibody-based peptide nucleic acid-mediated Pretargeting: in vivo proof of principle","volume":"59","author":"Westerlund","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0265","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1039\/D2CS00133K","article-title":"Noncovalent interactions in proteins and nucleic acids: beyond hydrogen bonding and \u03c0-stacking","volume":"51","author":"Jena","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2026.115978_bb0270","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/bc200298v","article-title":"Synthesis of phosphine and antibody\u2013azide probes for in vivo Staudinger ligation in a pretargeted imaging and therapy approach","volume":"22","author":"Vugts","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/acs.bioconjchem.4c00024","article-title":"Bioorthogonal radiolabeling of Azide-modified Bacteria using [18F]FB-sulfo-DBCO","volume":"35","author":"Alanizi","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0280","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1002\/anie.200906294","article-title":"In vivo chemistry for pretargeted tumor imaging in live mice","volume":"49","author":"Rossin","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115978_bb0285","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2967\/jnumed.113.123745","article-title":"Diels\u2013Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody","volume":"54","author":"Rossin","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0290","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1021\/acs.molpharmaceut.5b00294","article-title":"Optimization of a Pretargeted strategy for the PET imaging of colorectal carcinoma via the modulation of Radioligand pharmacokinetics","volume":"12","author":"Zeglis","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0295","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1021\/acs.molpharmaceut.9b00062","article-title":"Toward the optimization of click-mediated Pretargeted Radioimmunotherapy","volume":"16","author":"Membreno","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0300","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/acs.molpharmaceut.4c01129","article-title":"Head-to-head comparison of the in vivo performance of highly reactive and polar (18)F-labeled Tetrazines","volume":"22","author":"Hvass","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0305","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7150\/thno.14742","article-title":"Conformationally strained trans-Cyclooctene (sTCO) enables the rapid construction of 18F-PET probes via Tetrazine ligation","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115978_bb0310","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acsptsci.1c00007","article-title":"Lipophilicity and click reactivity determine the performance of bioorthogonal tetrazine tools in pretargeted in vivo chemistry","volume":"4","author":"Steen","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.addr.2026.115978_bb0315","doi-asserted-by":"crossref","first-page":"15297","DOI":"10.1021\/acs.jmedchem.1c01326","article-title":"Development of the first aliphatic (18)F-labeled Tetrazine suitable for Pretargeted PET imaging-expanding the bioorthogonal tool box","volume":"64","author":"Battisti","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0320","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2967\/jnumed.112.115840","article-title":"A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels\u2013Alder Click Chemistry","volume":"54","author":"Zeglis","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2967\/jnumed.115.163824","article-title":"Pretargeted Immuno-PET of pancreatic Cancer: overcoming circulating antigen and internalized antibody to reduce radiation doses","volume":"57","author":"Houghton","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/acs.bioconjchem.5b00504","article-title":"18F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels\u2013Alder Click Chemistry","volume":"27","author":"Meyer","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0335","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acs.bioconjchem.6b00235","article-title":"Pretargeted PET imaging using a site-specifically labeled Immunoconjugate","volume":"27","author":"Cook","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0340","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/1535-7163.MCT-16-0503","article-title":"Establishment of the in vivo efficacy of Pretargeted Radioimmunotherapy utilizing inverse Electron demand Diels-Alder click chemistry","volume":"16","author":"Houghton","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2026.115978_bb0345","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1021\/acs.molpharmaceut.9b00746","article-title":"Dual radionuclide Theranostic Pretargeting","volume":"16","author":"Kein\u00e4nen","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0350","doi-asserted-by":"crossref","first-page":"28316","DOI":"10.1073\/pnas.2009960117","article-title":"Harnessing 64Cu\/67Cu for a theranostic approach to pretargeted radioimmunotherapy","volume":"117","author":"Kein\u00e4nen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2026.115978_bb0355","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2967\/jnumed.124.267624","article-title":"Optimizing the therapeutic index of sdAb-based radiopharmaceuticals using pretargeting","volume":"65","author":"Poty","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0360","doi-asserted-by":"crossref","first-page":"15850","DOI":"10.1073\/pnas.1506542112","article-title":"Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET\/NIRF imaging of pancreatic cancer","volume":"112","author":"Houghton","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2026.115978_bb0365","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.7150\/thno.16744","article-title":"A Pretargeted approach for the multimodal PET\/NIRF imaging of colorectal Cancer","volume":"6","author":"Adumeau","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115978_bb0370","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1078-0432.CCR-18-1650","article-title":"Leveraging bioorthogonal click chemistry to improve 225Ac-Radioimmunotherapy of pancreatic ductal adenocarcinoma","volume":"25","author":"Poty","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115978_bb0375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2967\/jnumed.123.266388","article-title":"212Pb-pretargeted theranostics for pancreatic cancer","volume":"65","author":"Bauer","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addr.2026.115978_bb0380","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1021\/acs.jmedchem.4c02281","article-title":"An 211At-labeled Tetrazine for Pretargeted therapy","volume":"68","author":"Herth","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0385","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/D2MD00360K","article-title":"Pretargeted imaging beyond the blood-brain barrier","volume":"14","author":"Shalgunov","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0390","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1021\/acs.molpharmaceut.5c01180","article-title":"Pretargeted Immuno-PET enables monoclonal antibody imaging beyond the blood-brain barrier","volume":"22","author":"Gustavsson","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0395","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s11307-022-01744-y","article-title":"Non-invasive imaging of antisense oligonucleotides in the brain via in vivo click chemistry","volume":"24","author":"Cook","year":"2022","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.addr.2026.115978_bb0400","doi-asserted-by":"crossref","unstructured":"B.E. Cook, T.C. Pickel, S. Nag, P.N. Bolduc, R. Beshr, A. Forsberg Mor\u00e9n, C. Muste, G. Boscutti, D. Jiang, L. Yuan, P. Datta, P. Ochniewicz, Y. Khani Meynaq, S.-P. Tang, C. Plisson, M. Amatruda, Q. Zhang, J.M. DuBois, A. Delavari, S.K. Klein, I. Polyak, A. Shoroye, S. Girmay, C. Halldin, L. Martarello, E.A. Peterson, M. Kaliszczak, PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistry, Sci. Transl. Med., 17 eadl1732.","DOI":"10.1126\/scitranslmed.adl1732"},{"key":"10.1016\/j.addr.2026.115978_bb0405","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1021\/acs.bioconjchem.8b00385","article-title":"Dendrimer scaffold for the amplification of in vivo Pretargeting ligations","volume":"29","author":"Cook","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/acs.bioconjchem.4c00572","article-title":"PSMA-targeted intracellular self-assembled probe for enhanced PET imaging","volume":"36","author":"Zhang","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0415","article-title":"A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115978_bb0420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nucmedbio.2020.06.007","article-title":"Review: PET imaging with macro- and middle-sized molecular probes","volume":"92","author":"Mukai","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2026.115978_bb0425","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijpharm.2018.05.014","article-title":"Urokinase injection-triggered clearance enhancement of a 4-arm PEG-conjugated (64)cu-bombesin analog tetramer: a novel approach for the improvement of PET imaging contrast","volume":"545","author":"Matsumura","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0430","article-title":"Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker","volume":"29","author":"Lundmark","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2026.115978_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114361","article-title":"VyPAL2 peptide asparaginyl ligase enables versatile workflows for radiolabeling single-domain antibody-based theranostics","volume":"388","author":"Declercq","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115978_bb0440","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.7150\/thno.84865","article-title":"Click-to-release: cleavable Radioimmunoimaging with [(89)Zr]Zr-DFO-trans-Cyclooctene-Trastuzumab increases tumor-to-blood ratio","volume":"13","author":"Vlastara","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115978_bb0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13550-025-01213-x","article-title":"A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points","volume":"15","author":"Sarkar","year":"2025","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.addr.2026.115978_bb0450","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acs.bioconjchem.4c00337","article-title":"Scission-enhanced molecular imaging (SEMI)","volume":"35","author":"Quintana","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030719","article-title":"\u201cClick-to-clear\u201d: a strategy to minimize radioactivity from the blood pool utilizing Staudinger ligation","volume":"15","author":"Soni","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115978_bb0460","unstructured":"A Phase I Study of Pretargeted PET Imaging Using 64Cu-Tz-SarAr and a Trans-Cyclooctene-Modified Humanized 5B1 Immunoconjugate (hu5B1-TCO) in Patients With Pancreatic, Bladder Cancer, Gastrointestinal Malignancies or Solid Tumors With Elevated CA19\u20139, 2023."},{"key":"10.1016\/j.addr.2026.115978_bb0465","series-title":"TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers, a Phase 0\/I Study","year":"2025"},{"key":"10.1016\/j.addr.2026.115978_bb0470","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41596-023-00825-8","article-title":"Click chemistry: a transformative technology in nuclear medicine","volume":"18","author":"Bauer","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2026.115978_bb0475","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41577-025-01207-9","article-title":"Fifty years of monoclonals: the past, present and future of antibody therapeutics","volume":"25","author":"Chan","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2026.115978_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2024.108976","article-title":"Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer","volume":"140-141","author":"Mack","year":"2025","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2026.115978_bb0485","article-title":"Apoptosis-amplified intracellular paclitaxel nanoparticle formation enhances microtubule aggregation and PANoptosis","volume":"65","author":"Liu","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115978_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115978_bb0495","doi-asserted-by":"crossref","first-page":"14112","DOI":"10.1002\/anie.201305969","article-title":"Click to release: instantaneous doxorubicin elimination upon tetrazine ligation","volume":"52","author":"Versteegen","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2026.115978_bb0500","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1021\/jacs.7b11217","article-title":"Unraveling Tetrazine-triggered bioorthogonal elimination enables chemical tools for ultrafast release and universal cleavage","volume":"140","author":"Carlson","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0505","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/jacs.5c11564","article-title":"A versatile bioorthogonal Theranostic platform enables relay activation of tumor cell imaging and targeted protein degradation","volume":"148","author":"Sun","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0510","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1021\/acs.jmedchem.4c02965","article-title":"Novel bioorthogonal Theranostic scaffold enables on-target drug release and real time monitoring in vivo","volume":"68","author":"Pang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0515","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03880-y","article-title":"Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice","volume":"9","author":"Rossin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115978_bb0520","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1021\/acs.jmedchem.3c01459","article-title":"Bioorthogonal bond cleavage chemistry for on-demand prodrug activation: opportunities and challenges","volume":"66","author":"Min","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091380","article-title":"Click-to-release for controlled immune cell activation: tumor-targeted unmasking of an IL12 prodrug","volume":"18","author":"den Brok","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.addr.2026.115978_bb0530","article-title":"Conditional relay activation of theranostic prodrug by pretargeting bioorthogonal trigger and fluorescence-guided visible light irradiation","volume":"64","author":"Li","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2026.115978_bb0535","doi-asserted-by":"crossref","first-page":"13163","DOI":"10.1021\/jacs.4c00731","article-title":"Controlled in situ self-assembly of biotinylated trans-Cyclooctene nanoparticles for orthogonal dual-Pretargeted near-infrared fluorescence and magnetic resonance imaging","volume":"146","author":"Weng","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0540","doi-asserted-by":"crossref","first-page":"59787","DOI":"10.1021\/acsami.1c21062","article-title":"Assembly transformation jointly driven by the LAP enzyme and GSH boosting Theranostic capability for effective tumor therapy","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115978_bb0545","doi-asserted-by":"crossref","first-page":"41657","DOI":"10.1021\/jacs.5c13182","article-title":"Cell membrane-anchored click reaction enhances porphyrin uptake for highly efficient photodynamic therapy of breast tumors","volume":"147","author":"Ma","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115978_bb0550","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1039\/C4SC01348D","article-title":"Conformationally strained trans-Cyclooctene with improved stability and excellent reactivity in Tetrazine ligation","volume":"5","author":"Darko","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115978_bb0555","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1021\/mp500275a","article-title":"Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction","volume":"11","author":"Rossin","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115978_bb0560","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.bioconjchem.1c00537","article-title":"Strain-promoted azide-alkyne cycloaddition-based PSMA-targeting ligands for multimodal intraoperative tumor detection of prostate cancer","volume":"33","author":"Derks","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115978_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409945","article-title":"Conjugation chemistry markedly impacts toxicity and biodistribution of targeted nanoparticles, mediated by complement activation","volume":"37","author":"Zaleski","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115978_bb0570","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41573-026-01411-9","article-title":"Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies","volume":"25","author":"Rudolph","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115978_bb0575","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41587-025-02592-1","article-title":"Induced proximity at the cell surface","volume":"43","author":"Till","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2026.115978_bb0580","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s44160-025-00815-6","article-title":"In-brain synthesis of receptor-based protease sensors by coupling ligand-directed chemistry and click chemistry","volume":"4","author":"Sakamoto","year":"2025","journal-title":"Nat. Synth."},{"key":"10.1016\/j.addr.2026.115978_bb0585","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsnano.9b06905","article-title":"Trans-Cyclooctene-functionalized PeptoBrushes with improved reaction kinetics of the Tetrazine ligation for Pretargeted nuclear imaging","volume":"14","author":"Steen","year":"2020","journal-title":"ACS Nano"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:18:34Z","timestamp":1791857914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":117,"alternative-id":["S0169409X26002127"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115978","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioorthogonal chemistries for theranostics and radioconjugates","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115978"}}